Cedars-Sinai Heart Institute, Los Angeles, California.
J Am Coll Cardiol. 2018 Jan 16;71(2):193-200. doi: 10.1016/j.jacc.2017.11.013.
Mechanistic exploration has pinpointed nanosized extracellular vesicles, known as exosomes, as key mediators of the benefits of cell therapy. Exosomes appear to recapitulate the benefits of cells and more. As durable azoic entities, exosomes have numerous practical and conceptual advantages over cells. Will cells end up just being used to manufacture exosomes, or will they find lasting value as primary therapeutic agents? Here, a venerable natural process-the generation of honey-serves as an instructive parable. Flowers make nectar, which bees collect and process into honey. Cells make conditioned medium, which laboratory workers collect and process into exosomes. Unlike flowers, honey is durable, compact, and nutritious, but these facts do not negate the value of flowers themselves. The parallels suggest new ways of thinking about next-generation therapeutics.
机制探索已经确定,纳米级细胞外囊泡(称为外泌体)是细胞治疗益处的关键介质。外泌体似乎再现了细胞的益处,甚至更多。作为持久的无氮实体,外泌体相对于细胞具有许多实际和概念上的优势。细胞最终是否只会被用来制造外泌体,还是会作为主要治疗剂找到持久的价值?在这里,一个古老的自然过程——蜂蜜的产生——可以作为一个有益的寓言。花朵产生花蜜,蜜蜂采集并加工成蜂蜜。细胞产生条件培养基,实验室工作人员采集并加工成外泌体。与花朵不同,蜂蜜持久、紧凑且营养丰富,但这些事实并不能否定花朵本身的价值。这些相似之处为下一代治疗方法提供了新的思路。